Divi's Laboratories

Divi's Laboratories Limited
	Divi's Laboratories' logo
Formerly	Divi's Research Centre
Company type	Public
Traded as	BSE: 532488; NSE: DIVISLAB;
ISIN	INE361B01024
Industry	Pharmaceuticals
Founded	12 October 1990 (34 years ago)
Headquarters	Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana, India
Key people	Murali Krishna Prasad Divi (MD); Satchandra Kiran Divi (CEO);
Products	Active Pharmaceutical Ingredients ; Nutraceuticals
Services	Custom synthesis
Revenue	₹9,712 crore (US$1.1 billion) (2025)
Operating income	₹2,916 crore (US$340 million) (2025)
Net income	₹2,194 crore (US$260 million) (2025)
Total assets	₹16,932 crore (US$2.0 billion) (2025)
Total equity	₹14,969 crore (US$1.8 billion) (2025)
Owner	Divi Satchandra Kiran (20.34%); Nilima Motaparti (20.34%); Divi Swarna Latha (5.27%); Divis Biotech Private Limited (3.01%); Murali Krishna Prasad Divi (2.85%);
Number of employees	13,884 (2020)
Subsidiaries	Divis Laboratories (USA) Inc; Divi’s Laboratories Europe AG; Divi’s Nutraceuticals;
Website	divislabs.com
	Footnotes / references; Financials as of 31 March 2025.

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.^[2]^[3]^[4]^[5] The company manufactures and custom synthesizes generic APIs, intermediates.^[6]^[7] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals.^[8] Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.^[9]

History

The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.^[10] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana.^[11] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.^[11]

The company went public with its initial public offering (IPO) on 17 February 2003.^[12]^[10] In 2010, the company established a research centre in Hyderabad.^[11]